Edesa Biotech
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $50 | $0 | $0 | $0 |
Gross Profit | -25 | -25 | -25 | -25 |
EBITDA | -4,271 | -2,315 | -2,197 | -1,694 |
EBIT | -4,296 | -2,341 | -2,223 | -1,720 |
Net Income | -4,218 | -2,247 | -2,228 | -1,749 |
Net Change In Cash | 50 | 0 | 0 | 0 |
Free Cash Flow | -2,051 | -2,087 | -1,765 | -1,750 |
Cash | 10,003 | 12,051 | 10,792 | 12,361 |
Basic Shares | 8,253 | 7,972 | 7,059 | 7,022 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -119 | -186 | -183 | -118 |
EBITDA | -7,065 | -5,983 | -9,222 | -17,429 |
EBIT | -7,184 | -6,169 | -9,222 | -17,548 |
Net Income | -7,185 | -6,170 | -8,374 | -17,548 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,322 | -4,890 | -6,636 | -12,284 |
Cash | 10,792 | 1,037 | 5,361 | 7,090 |
Basic Shares | 5,676 | 3,197 | 2,858 | 2,096 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.49 |
2025-12-31 | -$0.28 |
2025-09-30 | -$0.32 |
2025-06-30 | -$0.25 |